Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder

NCT: NCT07282678 · NOT_YET_RECRUITING

NCT IDNCT07282678
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2029-03
SponsorPulvinar Neuro, LLC (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this research study is to investigate a closed-loop transcranial alternating current stimulation (tACS) device to evaluate its ability to reduce symptoms of major depressive disorder

Frequently Asked Questions

What is Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder?

Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder is a clinical trial registered under NCT07282678. Current status: NOT_YET_RECRUITING.

What is the status of NCT07282678?

The current status of NCT07282678 (Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder) is: NOT_YET_RECRUITING.

When did Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder start?

Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑